PRO-DEX, INC. Deferred Costs, Current
PRO-DEX, INC. (PDEX) had Deferred Costs, Current of $70.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2026-09-03
- 2026-06-30: Deferred Costs, Current $70.00K.
- 2026-03-31: Deferred Costs, Current $40.00K.
- 2025-12-31: Deferred Costs, Current $174.00K.
- 2025-09-30: Deferred Costs, Current $32.00K.
| Period end | Deferred Costs, Current |
|---|---|
| 2026-06-30 | $70.00K 10-K · filed 2026-09-03 |
| 2026-03-31 | $40.00K 10-Q · filed 2026-04-30 |
| 2025-12-31 | $174.00K 10-Q · filed 2026-01-29 |
| 2025-09-30 | $32.00K 10-Q · filed 2025-10-30 |
| 2025-06-30 | $24.00K 10-K · filed 2026-09-03 |
| 2025-03-31 | $141.00K 10-Q · filed 2025-05-01 |
| 2024-12-31 | $152.00K 10-Q · filed 2025-01-30 |
| 2024-09-30 | $211.00K 10-Q · filed 2024-10-31 |
| 2024-06-30 | $262.00K 10-K · filed 2025-09-04 |
| 2024-03-31 | $331.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $412.00K 10-Q · filed 2024-02-08 |
| 2023-09-30 | $591.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $494.00K 10-K · filed 2024-09-05 |
| 2023-03-31 | $279.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $877.00K 10-Q · filed 2023-02-02 |
| 2022-09-30 | $587.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $710.00K 10-K · filed 2023-10-13 |
| 2022-03-31 | $341.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $424.00K 10-Q · filed 2022-02-03 |
| 2021-09-30 | $184.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $193.00K 10-K · filed 2022-09-08 |
| 2021-03-31 | $173.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $138.00K 10-Q · filed 2021-02-04 |
| 2020-09-30 | $142.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $155.00K 10-K · filed 2021-09-09 |
| 2020-03-31 | $391.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $492.00K 10-Q · filed 2020-02-06 |
| 2019-09-30 | $493.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $430.00K 10-K · filed 2020-09-10 |
| 2019-03-31 | $267.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $175.00K 10-Q · filed 2019-02-07 |
| 2018-09-30 | $82.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $32.00K 10-K · filed 2019-09-12 |
| 2017-12-31 | $10.00K 10-Q · filed 2018-02-08 |
| 2017-06-30 | $12.00K 10-K · filed 2018-09-13 |
| 2017-03-31 | $3.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $582.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $493.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $238.00K 10-K · filed 2017-09-14 |
| 2015-06-30 | $853.00K 10-K · filed 2016-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |